Does Jardiance Cause UTIs?
Jardiance (empagliflozin), an SGLT2 inhibitor for type 2 diabetes, carries a risk of urinary tract infections (UTIs). Clinical trials and post-marketing data show increased UTI incidence compared to placebo, linked to its mechanism of boosting urinary glucose excretion, which promotes bacterial growth.[1][2]
FDA prescribing information lists genitourinary infections, including UTIs, as common adverse reactions (affecting 7-9% of patients vs. 6% on placebo in trials). Serious cases like urosepsis occur rarely (<1%).[3]
How Common Are UTIs on Jardiance?
In pivotal EMPA-REG OUTCOME trial (n=7,020), uncomplicated UTIs hit 8.6% of Jardiance users vs. 6.2% placebo over 3 years. Women face higher rates (10-12%) than men (5-7%). Risk rises with poor diabetes control or prior infections.[1][4]
Real-world studies confirm this: a 2022 meta-analysis of 58 trials found SGLT2 inhibitors elevate UTI odds by 25% (OR 1.25, 95% CI 1.12-1.39).[5]
Why Does Jardiance Increase UTI Risk?
It inhibits sodium-glucose cotransporter 2 in kidneys, spilling glucose into urine (glycosuria). This feeds bacteria like E. coli, common in UTIs. Volume depletion from diuresis may also impair bladder flushing.[2][6]
Not every patient gets UTIs—risk factors include female sex, age >65, catheter use, or immunosuppression.
What Do Patients Report About UTIs?
User forums and FDA adverse event reports (FAERS) describe symptoms like burning urination, frequency, and foul-smelling urine starting weeks into treatment. Some resolve with antibiotics; others lead to discontinuation (1-2% of cases).[3][7]
How to Prevent UTIs on Jardiance?
Drink plenty of water (2-3 liters daily), urinate after sex, practice hygiene, and monitor blood sugar. Providers may prescribe low-dose antibiotics prophylactically for recurrent cases. Report symptoms promptly to avoid kidney involvement.[3][6]
Does It Affect Men Differently?
Men see lower UTI rates but higher risk of genital infections like balanitis (3-4% vs. <1% placebo), sometimes mistaken for UTIs. Prostate issues amplify risk.[4]
When to Stop Jardiance for UTI?
Discontinue if fever, flank pain, nausea, or blood in urine signal pyelonephritis. Restart after clearance if benefits outweigh risks.[3]
Alternatives with Lower UTI Risk?
Other diabetes drugs like GLP-1 agonists (e.g., Ozempic) or DPP-4 inhibitors (e.g., Januvia) show minimal UTI signals. Metformin has neutral/low risk. Switch if UTIs recur.[5][8]
[1]: EMPA-REG OUTCOME trial (NEJM, 2015)
[2]: Jardiance mechanism (Boehringer Ingelheim)
[3]: FDA Label for Jardiance
[4]: SGLT2 UTI meta-analysis (Diabetes Care, 2022)
[5]: Cochrane Review SGLT2 inhibitors (2021)
[6]: UpToDate: SGLT2 side effects
[7]: FDA FAERS database query
[8]: ADA Standards of Care 2023